Skip to main content
IDYA
NASDAQ Life Sciences

$300M Stock Offering Priced at $27 by IDEAYA, Below Market

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$28.91
Mkt Cap
$2.766B
52W Low
$20.5
52W High
$39.28
52W Position info
41% above low
Off High info
26% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

IDYA sits 41% above its 52-week low of $20.5 on elevated volume (2.2× avg).

Summary

IDEAYA Biosciences priced a $300 million common stock offering at $27 per share, a discount to its current trading price. This capital raise, which represents over 10% of the company's market value, will dilute existing shareholders. The offering follows a 424B5 filing yesterday that announced the launch of the public offering. This financing is expected to fund the company's ongoing clinical development, building on recent positive Phase 2/3 trial results for darovasertib and new strategic partnerships.

At the time of this announcement, IDYA was trading at $28.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $20.50 to $39.28. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IDYA - Latest Insights

IDYA
Nov 03, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.36
Real-time Price: $26.47 info
Change: -$4.89 (-16%) info
Market Cap: $2.561B info
IDYA
Nov 03, 2026, 6:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $31.64
Real-time Price: $26.47 info
Change: -$5.17 (-16%) info
Market Cap: $2.561B info
IDYA
Oct 19, 2026, 7:08 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.50
Real-time Price: $26.47 info
Change: -$7.03 (-21%) info
Market Cap: $2.561B info
IDYA
Aug 19, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $37.93
Real-time Price: $26.47 info
Change: -$11.46 (-30%) info
Market Cap: $2.561B info
IDYA
Aug 04, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $36.11
Real-time Price: $26.47 info
Change: -$9.64 (-27%) info
Market Cap: $2.561B info